p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors

Eduardo Cepeda Cañedo(Jewish General Hospital), Josie Ursini‐Siegel(Jewish General Hospital)

JCI Insight

January 20, 2021

10.1172/jci.insight.138382

Cited by 6

Related Papers

ShcA signalling is essential for tumour progression in mouse models of human breast cancer

|The EMBO Journal|2008|159

STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer

|Nature Communications|2021|61

Complex I inhibition combined with TLR activation in the breast tumor microenvironment educates cytotoxic neutrophils

|Science Advances|2025|3